Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4200-0.3000 (-6.36%)
At close: 04:00PM EST
Advertisement
Sign in to post a message.
  • C
    Christopher
    Bought 1400 shares today. I own now 3600 shares -average 5,3. I believe in this company.
    Bullish
  • f
    francis
    Just added 350 shares. It took 10 min. to fill the order which indicates manipulation IMO.
    only 6 shares went through and the rest took over 10 min to fill.
    Bullish
  • f
    francis
    John, Derek, and Jason should just sell shares to each other so they can feel they accomplished something for the day.
  • P
    Paul
    Exert From Article

    EB: How do you think the market/industry sector will change? Are there any speculations in terms of major collaborations or acquisitions we will see in the near or far future that may potentially compete with your new combined offering?
    SS: We at BioDiscovery have had a great and close collaboration going on with Illumina  over the past year. We designed a new cytogenetic microarray with Illumina, which is just about to be marketed more actively. This is the first new cytogenetic microarray on the market in at least ten years. It has a lot of significant advantages over the legacy products. Bionano, is completely open and interested to continue expanding this market because the BioDiscovery/Illumina relationship is complementary to what they are doing and it expands both microarray and NGS applications. This, of course, will also result in a strong glue between Bionano and Illumina. This strong, collaborative partnership will be of benefit to the entire community.

    https://enlightenbio.blog/2021/11/23/bionano-genomics-acquiring-biodiscovery-the-perfect-alignment-of-the-stars/
  • e
    ebby
    The board is dominated by Shorts who spreading FUD, dragging the price down. This stock short interest is high! Real investors, be strong! Don’t be shaking out! We’re at the end of the tunnel!
  • B
    Brian
    I can't wait for this 'risk off' period to end. It's bewn a painful few months:(
  • M
    Mark S
    Near everyone on the board is trashing bngo. Talk about contrary indications. When the stock was heading to 15 it was all "to the moon" blah, blah, blah. That was the worst time to buy. Now bngo is looking very attractive. I just wish I had more $ to buy.
  • R
    ROBERTO
    “Bionano Genomics Appoints Dr. Keith Gligorich, Seasoned Leader in CLIA-Certified CAP-Accredited Lab Operations, as VP Operations for Bionano Laboratories”
    We continue acquiring great talent!!!
    Bullish
  • g
    gregory
    How manipulated is this stock? NNDM is up 10% on 109% increase in revenue. They build 3d printers. BNGO 112% revenue increase and here we are. Game changing diagnostic abilities to cure illness and disease vs 3d printers.
  • D
    Daniel
    The whole market will spike on Monday

    Panic sellers were overreacting today
  • T
    Todd
    I have no idea what BNGO will do Monday - I am still waiting for a tradeable bottom. That said, I think the market will be up big on Monday - even though the omicron variant is more contagious - it appears the symptoms are very mild - great news - there should be limited need to shut down over something with mild symptoms...If you get it, just like a couple of days and it passes...If anyone has heard anything different - please comment...
  • A
    Archimedes
    Another strong addition to the Bionano team... Dr. Keith Gligorich, Seasoned Leader in CLIA-Certified CAP-Accredited Lab Operations, as VP Operations for Bionano Laboratories!
    Bullish
  • P
    Peter
    There is a cost dynamic to consider. Say a lab provider gets payer reimbursement of $10,000 for a cytogenomics test using the current technology (FISH, CMA, Karyotyping) and they net $1,000. But if the provider uses Saphyr they net $5,000. That's great for a while until the payer catches on that there's a cheaper way to get the same or better results. The payer would then lower its reimbursement schedule for that provider - and all other lab providers because the payer knows the test result can be obtained at a much lower price. Therefore, Saphyr at first would be a road to greater profits but eventually would not be optional for any provider - it would be NECESSARY!!

    If anyone can show some example LDT pricing for cytogenomics testing that would be interesting to know. Even better to know, the net cost of current technology versus Saphyr.
  • R
    Ross L
    The findings by OGM were concordant with those obtained by CMA and NGS for copy number variants (CNVs) and FISH and karyotyping for balanced structural variations (SVs) such as inversions and translocations. Sensitivity compared to CMA was 96% (22/23 CNVs detected) excluding copy neutral loss of heterozygosity calls. Sensitivity compared to karyotyping and FISH was 100% (98/98 loci detected). OGM also revealed substantially more SVs than the traditional methods, including an additional 51 CNVs and 20 SVs.

    https://finance.yahoo.com/news/bionano-genomics-announces-peer-reviewed-130000446.html
    SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announce
    SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announce
    finance.yahoo.com
  • r
    rabbi
    They had some interesting insights about BNGO on (http://financialdeals.tech). Definitely made me think twice about the company.
  • R
    ROBERTO
    Before Ronnie start making bad comments please note the market is red for everyone and this is not related to anything wrong with BNGO
    Bullish
  • M
    Mentz
    This board is too funny. I love the doom and gloom. Has anyone looked at other small caps? Drops are significant across the board. Here are you options: buy more, sell, or hold. My losses are at 70%
  • R
    ROBERTO
    Can you see it? BNGO is just about to explode!
    No one can say exactly when but it’s been prepared to go up very soon.
    Bullish
  • N
    Nigel
    I dont know how people can say Holmlin is a disaster, he got the stock up from 50 cents to 15 dollars, maybe its just the people who's fault it is, are the ones who bought it at the wrong price!! 3-4 dollars is about right at this time!
  • V
    VICTOR
    Bionano’s Is on Track for Growth Thanks to Saphyr As I see it, the market at large is missing the forest for the trees. For the quarter ending Sep. 30, Bionano generated $4.7 million in sales, up 112% year-over-year. Just like what played out last quarter, this early stage company has once again posted triple-digit-percentage revenue growth. This was the sixth quarter in a row that the company has beat analyst revenue estimates. These strong results are due to increased installations of its Saphyr optical genome mapping (OGM) instrument. At this price it is a great buy... GO BNGO
Advertisement
Advertisement